Lee S, Chary M, Petersen B, Mascarenhas J O
Department of Medicine, Elmhurst Hospital Center, Icahn School of Medicine at Mount Sinai, Elmhurst, New York, USA.
Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2934-7.
Paraneoplastic neuropathies associated with leukemia are rare, and early diagnosis and treatment are crucial due to the potential for irreversible neurological deficits and delay in treatment of the leukemia. This is the first report to describe severe paraneoplastic orthostatic hypotension which resolved after treatment of the acute myeloid leukemia (AML). The patient is a 76 year-old woman who presented with progressive dizziness, anorexia, and fatigue. She had severe orthostatic hypotension (supine systolic blood pressure 186 mmHg and standing 79 mmHg). She was found to have AML, for which azacitidine was initiated, and orthostatic hypotension resolved after initiation of treatment. This case demonstrates a unique example of paraneoplastic sequelae remitting with treatment of the underlying hematologic neoplasm. Physicians should be aware of this unusual occurrence of autonomic neuropathy with AML as delay in treatment of the hematologic malignancy can lead to irreversible neurologic deficit and increased morbidity and mortality.
与白血病相关的副肿瘤性神经病变较为罕见,鉴于存在不可逆神经功能缺损及白血病治疗延误的可能性,早期诊断和治疗至关重要。这是首篇描述严重副肿瘤性直立性低血压在急性髓系白血病(AML)治疗后得以缓解的报告。患者为一名76岁女性,出现进行性头晕、厌食和疲劳症状。她患有严重的直立性低血压(仰卧位收缩压186 mmHg,站立位79 mmHg)。她被诊断为AML,开始使用阿扎胞苷治疗,治疗开始后直立性低血压得以缓解。该病例展示了一个独特的例子,即副肿瘤后遗症随潜在血液肿瘤的治疗而缓解。医生应意识到AML这种自主神经病变的不寻常情况,因为血液恶性肿瘤治疗的延误可能导致不可逆的神经功能缺损以及发病率和死亡率的增加。